Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.03 USD | -1.69% | +0.20% | -38.00% |
Financials (USD)
Sales 2024 * | 137M | Sales 2025 * | 215M | Capitalization | 4.62B |
---|---|---|---|---|---|
Net income 2024 * | -613M | Net income 2025 * | -584M | EV / Sales 2024 * | 44 x |
Net Debt 2024 * | 1.42B | Net Debt 2025 * | 1.25B | EV / Sales 2025 * | 27.2 x |
P/E ratio 2024 * |
-7.76
x | P/E ratio 2025 * |
-8
x | Employees | 553 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.27% |
Latest transcript on BridgeBio Pharma, Inc.
1 day | -1.69% | ||
1 week | +0.20% | ||
Current month | -19.05% | ||
1 month | -15.38% | ||
3 months | -30.93% | ||
6 months | -0.16% | ||
Current year | -38.00% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 14-12-31 |
Charles Homcy
FOU | Founder | 75 | 14-12-31 |
Founder | 73 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 16-02-29 |
Founder | 73 | 14-12-31 | |
Fred Hassan
BRD | Director/Board Member | 78 | 21-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 25.03 | -1.69% | 1,540,280 |
24-04-23 | 25.46 | +1.56% | 1,223,615 |
24-04-22 | 25.07 | +1.33% | 2,123,116 |
24-04-19 | 24.74 | -0.84% | 2,298,719 |
24-04-18 | 24.95 | -0.12% | 2,225,068 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.00% | 4.7B | |
-2.86% | 87.37B | |
+3.95% | 41.01B | |
-21.94% | 28.08B | |
+53.11% | 24.72B | |
-5.41% | 17.47B | |
-44.23% | 11.69B | |
-17.60% | 11.6B | |
-13.96% | 11.56B | |
-0.22% | 8.44B |
- Stock Market
- Equities
- BBIO Stock